In Mao’s study, the control group composed more healthy subjects and HBV carriers but less cirrhotic patients, and this precluded them evaluating the performance of serum GP73 to differentiate HCC from cirrhosis. The gene discussed is GOLM1; the disease is Cirrhosis.